structural studies, which revealed mechanisms that contribute to allergic sensitization.
THE BASICS OF 3-DIMENSIONAL STRUCTURE DETERMINATION
The determination of an x-ray crystal structure starts with the purification of a sufficient amount of highly concentrated and homogeneous protein (Fig 1) . Several factors that contribute to molecular variability need to be taken into consideration, including molecular variants, glycosylation, proteolysis, fragmentation, aggregation, precipitation, and/or molecular flexibility (see the text in this article's Online Repository at www.jacionline.org). The expression of recombinant allergens, either alone or as fusion proteins, has often proved successful for obtaining homogeneous protein preparations. [9] [10] [11] [12] Molecules naturally embedded in membranes, such as the histamine receptor, might require strategies involving protein solubilization. 13 Procuring soluble, properly folded, and pure protein is the most promising way to obtain diffraction-quality crystals and the major bottleneck in the structure determination process. The difficulty in obtaining diffraction-quality crystals promotes the development of complementary technologies, such as cryo-electron microscopy. 14 Screening of optimal conditions for crystal growth is performed either manually or by means of robotics. 15 Hundreds of conditions are tested by mixing the highly concentrated protein with different precipitants. A commonly used technique is based on ''hanging'' or ''sitting'' drops in multiwell plates, where crystals form by slowly concentrating the protein and precipitant through vapor diffusion. Once crystals are obtained, the x-rays to probe them are produced either by rotating anode generators found in most crystallography laboratories or at synchrotron stations. There are more than 120 stations dedicated to macromolecular crystallography experiments worldwide. 16 The diffraction pattern produced by exposing protein crystals to x-rays is analyzed to obtain an electron density map that is used for determination of a molecular model. [17] [18] [19] The overall quality of structural models, as measured by various parameters used for structure validation, has significantly improved over time. 20 Structure quality depends not only on the resolution of the collected diffraction data but also on the processing of these data. Resolution is the smallest distance in angstroms between 2 atoms that can be shown to be separated (see Fig E3 in this article's Online Repository at www.jacionline.org). The myoglobin structure determined in 1958 had a resolution of 6 A. Nowadays, resolutions as high as 0.48 A can be obtained. 21 Crystallography has evolved from manual determination of molecular models to the use of hardware and software that greatly enhances the efficiency and quality of data collection, data reduction, model building and refinement. These transformative developments allow rapid data processing, model construction, and refinement (optimization). 22, 23 Sophisticated software, such as HKL-3000, has enabled the determination of structures with ''speed and finesse.'' 22 Indeed, a process that used to take years or months is now performed in days or even in hours in optimal cases (see Fig E2) . The productivity of synchrotron stations, as measured based on structures determined, varies significantly and mostly depends on experimental protocols. 24 There is no correlation between beamline productivity and any aspect of physical setup of data collection hardware, beamline flux, or number of crystals used for diffraction. Frequent reports show that only 1 to 5 minutes of data collection time are needed to generate an entire data set sufficient for a good structure determination. 25 The most productive synchrotron stations still need roughly 20 hours of data collection time to produce 1 FIG 1. General outline of the process of structure determination by using x-ray crystallography. Crystals of horse Equ c 3 and Alt a 1 from Alternaria alternata grown by using the vapor diffusion technique and used for x-ray diffraction experiments are shown. The European Synchrotron Radiation Facility and Institute Laue-Langevin in Grenoble (France; 3, left; photographer: Christian Hendrich) is shown next to diffraction images obtained from a protein crystal used for structure determination (3N99; 3, right).
structure. There is still room for improvement of experimental protocols and software in the future.
THREE-DIMENSIONAL STRUCTURES OF MOLECULES INVOLVED IN IMMUNOLOGY AND ALLERGY
Immunologic processes result from the interaction of specialized molecules, the structure of which defines their function. Selected examples involved in adaptive and innate immunity are shown in Fig 2. The structure of MHC class II molecules expressed in vivo on the surfaces of antigenpresenting cells clearly revealed a groove that binds the peptides generated from antigen processing and presents them to T-cell receptors (Fig 2, A) . This action, together with costimulatory signals, leads to activation of T cells to release cytokines that interact with cytokine receptors in B cells (Fig 2, B) . Crystal structures of ovalbumin (Gal d 2) peptides bound to mouse MHC class II and a peptide from Cry j 1, a major allergen from the Japanese red cedar (Cryptomeria japonica), bound to HLA-DP5 also aid in our understanding of molecular recognition of allergens. 26, 27 The structural basis of the interaction of cytokines with their receptors has been investigated to better understand what induces the production of antibodies by B cells. Cytokine receptors of the IL-4/IL-13 system result from the assembly of different subunits. Interestingly, a single subunit can be shared by different cytokine receptors (ie, IL-4 receptor [IL-4R] a shared by IL-4/IL-4Ra/gc and IL-13/IL-4Ra/IL-13 receptor a1; Fig 2, B) . These molecular interactions determine mechanisms of cytokine action and influence disease phenotype and response to treatment. 28, 29 IgE antibodies eventually bind to high-affinity IgE receptors (FcεRI) on mast cells and basophils (Fig 2, C) . X-ray crystal structures showed the flexibility of IgE-Fc (consisting of the C 32, C 33, and C 34 domains). IgE-Fc adopts different conformations, ranging from an acutely bent structure of IgE-Fc when bound to the extracellular domains of the Fc 3RI a chain (Fig 2, C) to a diversity of conformations in solution, including a fully extended symmetric one. 30, 31 The unique slow dissociation rate of IgE from FcεRI was attributed in part to these conformational changes. This observation provides a strategy for the design of asthma therapeutics using peptides that would disrupt the interaction between IgE and its high-affinity IgE receptor. 31 The low-affinity IgE receptor (CD23, FcεRII) on B cells is a calcium-dependent molecule with a C-type lectin domain that contributes to the regulation of IgE levels. Calcium induces structural changes in CD23 that lead to additional interactions with IgE and a 30-fold increase in affinity for IgE (Fig 2, D) . 32 The crystal structure of IgE bound to CD23 revealed a mechanism of reciprocal allosteric inhibition with the high-affinity IgE receptor. 33 Structures of molecules involved in innate immunity have also been determined, including the extracellular domain of Toll-like receptors (TLRs). The structures of TLRs differ from the ''immunoglobulin-like'' extracellular domains of the B-and T-cell receptors mentioned above. For all these receptors, only the structures of the extracellular domains have been determined. Ten TLRs are known in human subjects, and they are formed by an N-terminal recognition domain, a single transmembrane helix, and a C-terminal signaling domain. The N-terminal domain recognizes pathogen-derived compounds or endogenous molecules released by the host in response to infection. 34 This domain adopts a typical horseshoe shape made of tandem copies of a motif known as the leucine-rich repeat. Its concave surface has ligand-binding capacity in most leucine-rich repeats. Two extracellular domains form a dimer upon ligand binding and activate signaling. The structure of TLR4, for example, has revealed the importance of its interaction with MD-2 and endotoxin for signaling activation (Fig 2, E) .
ALLERGEN STRUCTURE AS A DETERMINANT OF ALLERGIC DISEASE
Immunologic processes that lead to the development of allergic disease are strongly associated with structural features of the allergen (Fig 3) . Allergen exposure, which is critical to IgE sensitization, is determined in part by the function of the allergen and the degree of molecular stability required for the protein to become an allergen, both of which are defined by the allergen structure. Allergens must be either released to the environment (eg, pollens, spores, dander, or fecal particles) or made accessible through other paths (ingestion of foods, injection of venoms, or contact through skin or infection) to access the immune system. The function of the allergen can facilitate exposure in different ways. Some allergens are released to the environment because (Fig 3, A and D) .
of their reproductive function in pollen or spores. Others have a digestive function and are excreted in fecal particles. Additional factors determine exposure, such as the aerodynamic properties of particles that carry inhalant allergens.
One of the first functions gleaned from the x-ray crystal structure of allergens was obtained in 1992 for the major urinary proteins from mouse and rat. Both Mus m 1 and Rat n 1, which were not known as allergens at that time, are pheromone transporters and belong to the lipocalin family of proteins. Lipocalins consist of a b-barrel with a hydrophobic ligand-binding cavity (Fig 3, A) and are secreted in tears, urine, sweat, or saliva, which facilitates exposure. 35 Lipocalins are common mammalian inhalant allergens that are also found in cockroach (Bla g 4) and cow's milk (food allergen Bos d 5).
The first 3-dimensional structure of a clinically important allergen was Bet v 1, a pathogenesis-associated protein from birch pollen (Fig 3, B) . 36 Bet v 1 is the most extensively studied allergen from pollen. The IgE prevalence in temperate climate areas of the northern hemisphere (ie, Northern Europe) is high (>95%). Bet v 1 shows clinical cross-reactivity with homologous allergens from fruits and vegetables (ie, apples, celery, and carrot). 37 A large number of variants (n 5 18) have been identified in natural Bet v 1, sharing high amino acid sequence identity (approximately 95%). Their nomenclature has recently been revised by the Allergen Nomenclature Sub-Committee from the World Health Organization (WHO) and International Union of Immunological Societies (IUIS; www.allergen.org). 38, 39 Bet v 1.0101 is the major component of natural Bet v 1 (>50%) and the main sensitizer, whereas other isoforms (Bet v 1.0401 and Bet v 1.1001) induce only minimal IgE antibody responses. 40 Bet v 1.0101 and Bet v 1.0401 share the same fold, but differences in dimerization or aggregation could contribute to a decreased ability of the Bet v 1.0401 variant to elicit an allergic immune response. Interestingly, the fold of Bet v 1.0101 per se was demonstrated to be important for T H 2 polarization and induction of a strong IgE response by means of comparison with an engineered folding variant. 41 Nowadays, the Protein Data Bank (www.rcsb.org) contains the 3-dimensional structures of more than 100 allergens representing approximately 50 protein families from approximately 800 allergens currently present in the WHO/IUIS official database of systematic Allergen Nomenclature (see Tables E1 and E2 in this article's Online Repository at www.jacionline.org). A database of allergen families (http://www.meduniwien.ac.at/ allergens/allfam/) reports that allergens belong to a wide array of 186 protein families. 42, 43 The most frequent biochemical functions of allergens are protein hydrolysis, carbohydrate metabolism, binding of metal ions and lipids, storage and functions associated with the cytoskeleton. 42 Measurement of biological activity with a specific functional assay is the best way to confirm function, but this option is not always available. Sequence homology to a protein of known function might also be insufficient. 44 Determination of tertiary structure can delineate allergen function by defining the overall shape of the molecule, revealing specific functional residues, or both. 45 The major dust mite allergens Der p 1 and Der f 1 are cysteine proteases. Their catalytic site has been identified in the 3-dimensional structures of the native allergens (Fig 3, F) . 46, 47 In contrast, the cockroach allergen Bla g 2 folds as a typical pepsin-like aspartic protease but is devoid of aspartic protease activity because of specific substitutions in the catalytic site that were revealed by the crystal structure (Fig 3, E , and see Fig E1, A) . 48, 49 In other cases molecular flexibility confers a regulatory function, as seen in the calcium-binding allergens commonly found in pollen and in troponin, which regulates muscle contraction (ie, Bla g 6). 50 The first 3-dimensional structure of a representative of the 2 EF-hand allergen family was reported for Phl p 7 bound to calcium. 51 Differences observed in IgE antibody binding depending on allergen conformation suggest that conditions and conformation with optimal IgE reactivity should be selected for molecular diagnosis.
The storage peanut proteins Ara h 1 and Ara h 2 are food allergens with very different structural complexities. Ara h 1 is a trimer of 60-kDa bicupin-fold monomers, whereas Ara h 2 is a small monomeric a-helix protein (17 kDa; see Fig E4 in this article's Online Repository at www.jacionline.org). 11, 52 It has been suggested that the quaternary structure of Ara h 1 might play a role in its allergenicity by increasing molecular stability and preventing digestion of IgE antibody-binding epitopes. 53 However, there is no evidence that the differing tertiary structure of both allergens is responsible for differing allergenic potential. In fact, IgE antibody titers to Ara h 2, which has a simpler structure, have been reported as the best predictor of peanut allergy. [54] [55] [56] In general, 3-dimensional structural complexity of allergens does not seem to be related to their allergenicity.
Finally, determination of the x-ray crystal structure of allergens has revealed the existence of new structural groups of proteins. Alt a 1, the major allergen from Alternaria alternata, has a unique b-barrel structure that forms a ''butterfly-like'' dimer and is exclusively found in the Dothideomycetes and Sordariomycetes classes of fungi (Fig 3, C) . 57 The cockroach allergen Bla g 1 has an a-helical structure thus far only found in insects (Fig 3,  D) . 12, 58 Although the 3-dimensional structures of these and other allergens have been determined, their functions still are not well understood. 10, 57, 59 The cat allergen Fel d 1 has a uteroglobulinlike fold and consists of a dimer of heterodimers made exclusively of a-helices. Structures of recombinant Fel d 1 made by fusion of the monomers involved in each heterodimer have been determined. 60, 61 However, the native assembly of this major cat allergen remains unknown.
INFLUENCE OF ALLERGEN FUNCTION ON ALLERGENICITY
An interesting example of how an x-ray crystal structure revealed a function associated with allergenicity is illustrated by Der p 2. This dust mite allergen resembles MD-2, the LPSbinding component of the TLR4 signaling complex, which is involved in activation of the innate immune system. Both proteins have an immunoglobulin-like fold formed only of b-sheets (see Figs E1, B, and E4, A) . 62, 63 The surprisingly high structural similarity prompted an investigation as to whether Der p 2 would have a similar function. Der p 2 was not only able to mimic the function of MD-2 in mouse models of experimental asthma but was also able to reconstitute LPS-driven TLR4 signaling in the absence of MD-2, suggesting a possible role of Der p 2 in activation of innate immunity. 64 Results obtained with Der p 2 are supported by data demonstrating that low-level stimulation of TLRs drives T H 2 immune responses. [64] [65] [66] [67] [68] This discovery marked an important step in our understanding of possible innate immune pathways that lead to allergic sensitization. Until then, activation of the adaptive immune system was the main recognized path for allergy development. Proteolytic function had been considered to contribute to allergenicity by cleaving molecules involved in the immune response. 69, 70 Der p 1 can contribute to allergenicity through noncanonical pathways. Der p 1 was reported to directly promote IgE synthesis through cleavage of the low-affinity IgE receptor (CD23) on B cells and, indirectly, through cleavage of the a-subunit of the IL-2 receptor (CD25) in T cells. 71, 72 Der p 1 can also contribute to inflammation by inducing cytokine production and disrupting gap junctions in the lung epithelium, which would increase membrane permeability and facilitate transepithelial allergen delivery and processing. 69, 70, 73, 74 Structural studies have shown that an increasing number of allergens belonging to different structural families bind hydrophobic ligands and that these are potent stimulators of the innate immune system. 65 The crystal structure of Bla g 1 provided the first clues that this protein might be a lipid-binding protein (Fig 3, D) . Lipids in cockroach frass were identified as fatty acids that are known to activate TLR2 and TLR4. 75 Fig E1, B) . 12, 61, 62, 76 Other allergens, lacking internal cavities, can also bind lipidic ligands in different ways. Der p 5 consists of 3-helix bundles that tend to form multimers (see Fig E4, B) . A large hydrophobic cavity formed by each dimer has the potential to bind lipidic ligands. 10 Der p 7 has a similar structure to an LPS-binding protein involved in TLR4 activation and to the surfactant allergen Equ c 4.
9,77 The fold consists of two 4-strand antiparallel b-sheets that wrap around a long C-terminal helix (see Fig E4, C) . Although unable to bind LPS, Der p 7 bound the lipopeptide polymyxin B. 9 The specific contribution of allergen-associated lipids to allergenicity has been recently reviewed. 78 The interactions of these lipids with innate immunity are open to further investigation.
HOW CRYSTALLOGRAPHY CONTRIBUTES TO CLINICAL PRACTICE
The allergen structures determined by using x-ray crystallography provide the basis for improved diagnosis and therapy. An undesired side effect of immunotherapy is the induction of adverse reactions that can occur when administering increasing doses of the allergen during vaccination. To avoid these effects, hypoallergens with reduced IgE reactivity that preserve their capacity to induce T-cell responses have been designed as candidates for vaccination. One strategy is the disruption of the overall allergen fold. This has proved efficacious with hypoallergenic chemically modified extracts (allergoids) that are successful for immunotherapy in Europe. 79 Numerous variants of recombinant hypoallergens have also been designed, but only Bet v 1 variants have reached clinical trials, in which they have already shown promising results. 80 Recently, a dose-ranging immunotherapy study of a new recombinant hypoallergenic folding variant of Bet v 1 showed efficacy in an environmental exposure chamber. 81 Although knowledge of the 3-dimensional structure of the allergen is not always necessary for the production of unfolded variants, the disruption of the overall allergen fold can be effectively designed based on the modification of specific structural features. For example, mite group 2 hypoallergens were produced by mutating cysteines involved in the formation of disulfide bonds that preserve the immunoglobulin-like structure. 82, 83 Another strategy to produce hypoallergens consists of modifying residues involved in IgE antibody binding, without affecting the fold of the allergen. In this case knowledge of the 3-dimensional structure of the allergen is required. The best way to precisely locate the epitope recognized by an antibody is the determination of the structure of the allergen in complex with the antibody. For example, the structure of Bet v 1 in complex with the Fab fragment of an mAb that interfered with IgE antibody binding identified a dominant epitope also involved in IgE cross-reactivity with homologous allergens. 84, 85 The x-ray crystal structures of additional complexes revealed determinants of specificity and cross-reactivity. 47, [86] [87] [88] [89] [90] [91] Bla g 2 and Der p 1 have been extensively analyzed through the structures of 2 and 4 allergen-antibody complexes, respectively (Fig 3, E and F) . 47, [89] [90] [91] The structural basis of cross-reactivity was analyzed for mAb 4C1, which binds Der p 1 and Der f 1 in equivalent epitopes (Fig 3, F) . 47 It is not possible to obtain the milligram amounts of pure native IgE antibodies required for x-ray crystallography given their polyclonality and low concentration in sera compared with IgG antibodies (0.05%). Therefore recombinant IgE mAb, which were derived from combinatorial libraries from allergic patients, were used in complexes with bovine milk Bos d 5 (b-lactoglobulin; Fig 3, G) and timothy grass pollen Phl p 2. 87, 88 This strategy, combined with site-directed mutagenesis, is a powerful tool to identify the main residues involved in IgE antibody recognition and to produce hypoallergens. 47, 85, 92 Molecular allergy diagnosis has been shown to improve patient diagnosis compared with exclusively using clinical history and skin prick tests with allergen extracts. 37, [93] [94] [95] [96] [97] Structural analyses reveal relationships between homologous allergens and contribute to the design of panels of purified allergens for molecular diagnosis. Although a general rule suggests that cross-reactivity is likely among proteins that share a high degree of amino acid identity throughout the entire protein (>70%) and tends to be rare at less than 50% identity, exceptions do occur. [98] [99] [100] [101] [102] Predictions of cross-reactivity based on the overall homology among allergens can only be used as guidelines but lack precision. The 3-dimensional structure of allergens allows identification of solvent-exposed residues responsible for antibody recognition. 103 Ideally, the selection of representative molecules from highly cross-reactive groups of allergens and the inclusion of allergens with species-specific epitopes can simplify molecular diagnosis.
104,105

LOOKING INTO THE FUTURE
In the future, an increase in structure-function studies is expected by combining methodologies from the disciplines of medicine and structural biology. Cryoelectron microscopy will enable study of larger complexes of antigens and antibodies without the need to crystallize them. Use of the free electron laser as an x-ray source will allow investigations using nanocrystals and decrease the chances of structural changes caused by radiation damage. 106, 107 Nuclear magnetic resonance, which is currently only rarely used for structural studies of antigen-antibody complexes, is expected to have a higher impact on ligand screening and dynamic studies. As more structures become available, the ability to create informative homology models for hypothesis-driven research will be enhanced. Tighter interactions between functional and structural studies are expected to affect more significantly the drug discovery process. The creation of a big picture and better reproducibility will be possible by using sophisticated database systems that will organize and analyze structural data in biomedical laboratories. 108 X-ray crystallography has led to major contributions in clinical immunology and allergy. The 3-dimensional structures of molecules involved in immunologic processes and allergens, either alone or in complex with antibodies, have provided detailed information at the atomic level that reveals mechanisms of molecular interaction. Recombinant allergens are engineered to either preserve their native fold and amino acid composition or to have specific residues and/or the overall fold modified for reduced IgE reactivity, which might diminish side effects caused by increasing allergen doses administered during therapy. Recombinant allergens have already shown promising results in immunotherapy clinical trials. The structural information is being used to increase the accuracy of diagnosis and to design new forms of immunotherapy that will complement and improve current approaches to treat allergic disease.
DETERMINATION OF X-RAY CRYSTAL STRUCTURES OF BIOLOGICAL MOLECULES
Proteins are first purified from the natural source or from an in vitro expression system in high amounts (5-10 mg) to be used in crystallization experiments. An inherent variability associated with some natural or recombinant proteins is one of the main difficulties to overcome and might be a consequence of different factors that will be illustrated here with allergens as examples.
MOLECULAR POLYMORPHISMS
A common source of allergen variability is the presence of molecular polymorphisms that can impair crystallization if copurified from the natural source. As a guideline, isoallergens share amino acid identity of greater than 67%, and each isoallergen might have multiple forms of closely similar sequences (>90%) that are designated as variants or isoforms. This guideline was established by the WHO/IUIS Allergen Nomenclature Sub-Committee (www.allergen.org).
E1
The heterogeneity generated by the presence of these polymorphisms, especially by isoallergens, can impair crystallization, although not always. For example, despite a large number of polymorphisms reported for group 1 mite allergens (24 variants for Der p 1 and 10 for Der f 1), only 1 variant of each (Der p 1.0105 and Der f 1.0101) could be crystallized and used to solve the structures. E2 
GLYCOSYLATION
Molecular heterogeneity can result from glycosylation through addition of carbohydrates of different lengths to the side chains of proteins. Removal of carbohydrates by means of enzymatic digestion followed by purification of the deglycosylated allergen often is not efficient for production of high amounts of protein required for crystallography. Instead, N-glycosylation can be prevented by expressing recombinant proteins in Escherichia coli, which are not glycosylated, or by modifying the N-glycosylation sites to prevent glycosylation when expressing proteins in the yeast eukaryotic system Pichia pastoris, which tend to be hyperglycosylated. Such amino acid substitutions were introduced in Bla g 2 (N93Q), recombinant pro-Der p 1 (N132E), and recombinant Der p 1 (N52Q) to favor crystallization.
E3-E5
PROTEOLYSIS
Molecular heterogeneity caused by proteolysis is a common occurrence, especially when proteolytic enzymes (including allergens themselves) are present in the allergen source. An example is Der p 1, a cysteine protease that is expressed as a proenzyme and becomes enzymatically active after maturation, involving removal of 80 amino acids that cover the active site. The first structure of this allergen was recombinant C114A pro-Der p 1 (prevented from spontaneous maturation by mutating the active site cysteine). E4 A second structure was determined with active, mature recombinant Der p 1. E5 In this case allergen dimerization took place during crystal growth, and fortuitously, a loop from one molecule sterically blocked the catalytic cleft in the second molecule. E6 In the most recently determined structures of native Der p 1 and Der f 1, the catalytic cysteine was found to be oxidized, which might have contributed to the success of crystallization by rendering the molecule inactive. E6 
FRAGMENTATION
Some proteins break down into fragments that preserve their allergenic potential. The cockroach allergen Bla g 1 is one of them. This allergen is formed by approximately 100 consecutive amino acid repeats resulting from duplication and mutation of an original domain present only in other insect proteins involved in digestive or detoxifying functions.
E7,E8 Bla g 1 breaks into fragments containing different numbers of repeats. The basic structural unit of Bla g 1 was the first to be determined for this group of proteins and revealed a novel fold containing 2 consecutive repeats with a large internal hydrophobic cavity that contains lipids (Fig 3,  D) . The allergen is formed by several linked consecutive units. Despite fragmentation, the basic unit of Bla g 1 preserves the fold that exposes the epitopes involved in IgE antibody binding.
AGGREGATION-PRECIPITATION
Protein solubility at a high protein concentration (typically >3 mg/mL) is one of the usual prerequisites for crystallization. However, some proteins will not reach high concentrations without precipitating or aggregating. For example, proteins expressed in E coli do not always fold properly and might precipitate in inclusion bodies inside cells. A technique based on successive dialysis of these denatured proteins into buffers of different ionic strength helps them to refold into their native conformation. This has been applied efficiently for dust mite group 2 allergens. E9,E10 Another successful approach for proteins that did not express well alone or precipitated during purification is the use of fusion partners. Small allergens have shown an improved capacity to crystallize when expressed as fusions with a larger protein that stabilizes the construct and might contribute to crystal lattice formation. This approach has been successfully applied to the expression and crystallization of allergens fused to maltose-binding protein (MBP) and a variant of green fluorescent protein (GFP; ie, MBP-Der p 7, MBP-Ara h 2, and GFP-Bla g 1).
E8,E11,E12 The fused proteins might be optimized for different purposes. For example, the MBP was designed with surface entropy-reducing mutations to enhance crystallization. E13,E14 Another advantage of the fused proteins is to facilitate purification because of their affinity for certain column resins (MBP binds amylose affinity resin, GST binds glutathione S-transferase columns, and the polyhistidine tag attached to GFP binds nickel agarose resin). Fusion proteins can be designed to allow isolation of the allergen by using a specific protease, such as tobacco etch virus protease. E8 
MOLECULAR FLEXIBILITY
Some allergens have a regulatory function that involves molecular flexibility, which is determined by calcium binding to EF-hand motifs.
E15,E16 Nuclear magnetic resonance, which analyzes structures in solution, might be a more appropriate method for analysis of the dynamic structural changes. E17 Nevertheless, x-ray crystallography provided useful data for these regulatory proteins once certain conformations were stabilized with the appropriate calcium concentrations. E18 
ADDITIONAL MOLECULAR CHALLENGES FOR CRYSTALLOGRAPHY
Some proteins, such as receptors, are embedded in membranes, and their isolation requires specialized techniques, such as the use of detergents, or expression of only their extracellular fragments. They are usually complex macromolecules involving multiple subunits. Examples of these molecules involved in allergic disease include cytokines and TLRs and B-and T-cell receptors (Fig 2) . The codes refer to the structure of molecules that are not necessarily the same polymorphism reported in the WHO/IUIS Allergen Nomenclature database. 3D, Three-dimensional; (m), modified or mutated molecule; NMR, nuclear magnetic resonance; PDB, Protein Data Bank. *Allergen in complex with an antibody fragment. Structures selected from multiple PDB entries (>540 for hen egg lysozyme).
